|
CFL1 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.804200E-04 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.063900E-03 |
| Normal-vs-Stage2 |
3.927900E-02 |
| Normal-vs-Stage3 |
9.982000E-04 |
| Normal-vs-Stage4 |
1.419630E-01 |
| Stage1-vs-Stage2 |
8.426400E-01 |
| Stage1-vs-Stage3 |
8.687500E-02 |
| Stage1-vs-Stage4 |
6.731600E-01 |
| Stage2-vs-Stage3 |
2.279200E-01 |
| Stage2-vs-Stage4 |
8.314200E-01 |
| Stage3-vs-Stage4 |
2.522000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.798700E-04 |
| Normal-vs-AfricanAmerican |
2.377300E-03 |
| Normal-vs-Asian |
1.891990E-01 |
| Caucasian-vs-AfricanAmerican |
6.366200E-01 |
| Caucasian-vs-Asian |
6.530600E-01 |
| AfricanAmerican-vs-Asian |
7.636400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
8.366700E-04 |
| Normal-vs-Female |
1.005840E-04 |
| Male-vs-Female |
6.144000E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
1.078170E-03 |
| Normal-vs-Extreme_Weight |
1.881320E-03 |
| Normal-vs-Obese |
2.562000E-04 |
| Normal-vs-Extreme_Obese |
8.702400E-01 |
| Normal_Weight-vs-Extreme_Weight |
3.029200E-01 |
| Normal_Weight-vs-Obese |
9.852600E-01 |
| Normal_Weight-vs-Extreme_Obese |
2.271500E-02 |
| Extreme_Weight-vs-Obese |
2.305200E-01 |
| Extreme_Weight-vs-Extreme_Obese |
3.046400E-02 |
| Obese-vs-Extreme_Obese |
1.141700E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.019600E-04 |
| Normal-vs-Age(41-60Yrs) |
3.402200E-04 |
| Normal-vs-Age(61-80Yrs) |
1.460980E-03 |
| Normal-vs-Age(81-100Yrs) |
9.018000E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.148610E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
8.296200E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.904820E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.334800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.169600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.754800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
4.26660000000245E-05 |
| Normal-VS-Type2 PRCC |
5.548400E-02 |
| Normal-VS-KIRP CIMP |
1.479650E-03 |
| Normal-VS-Unclassified PRCC |
1.140060E-03 |
| Type1 PRCC-VS-Type2 PRCC |
5.938500E-03 |
| Type1 PRCC-VS-KIRP CIMP |
2.285700E-02 |
| Type1 PRCC-VS-Unclassified PRCC |
5.182600E-01 |
| Type2 PRCC-VS-KIRP CIMP |
5.761900E-03 |
| Type2 PRCC-VS-Unclassified PRCC |
1.860080E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
1.812250E-02 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.216120E-02 |
| Normal-vs-N1 |
5.796800E-03 |
| Normal-vs-N2 |
2.926400E-02 |
| N0-vs-N1 |
2.028400E-01 |
| N0-vs-N2 |
3.303800E-01 |
| N1-vs-N2 |
8.190200E-01 |
|
|
